Remove Cannabis Remove Clinical Trials Remove Download
article thumbnail

Press Release: Silo Pharma Secures Patent that May be Used for Psychedelics Delivery Technology

Cannabis Law Report

Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Presently, the company is working with researchers to build out these technologies and pave the way for clinical trials. Silo Pharma Inc. Looking to the Future. Silo Pharma Inc.

article thumbnail

Prohibition (UK) Publish…. PSYCH: THE PSYCHEDELICS AS MEDICINE REPORT

Cannabis Law Report

Download your free copy now. KEY FINDINGS FROM THE REPORT INCLUDE: While cannabis has already paved much of the way for psychedelics in terms of legal progress and changing public perception, psychedelics as medicines are already backed by a more powerful knowledge base comparatively.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MedXtractor Fills a Key Gap in Mental Health Treatments

Cannabis Law Report

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. For more information, visit the company’s website or download their investor presentation. Mental Health Challenges. Disclaimer.

article thumbnail

Cannabis for IBS: Treating Irritable Bowel Syndrome with Medical Marijuana

Greencamp

Many people are using cannabis for IBS with great success in managing symptoms like nausea, cramps and stomach pains. The science and research behind cannabis and IBS has linked the imbalances of our endocannabinoid system with certain IBS symptoms. This is where compounds from cannabis make their entrance. Here’s how.

article thumbnail

Use of Cannabis-based medicinal products: NICE guidelines

Cannabis Law Report

Cannabis-based medicinal products. Do not offer CBD to manage chronic pain in adults unless as part of a clinical trial. NICE has made research recommendations on the use of cannabis-based medicinal products for severe treatment-resistant epilepsy. the person’s clinical condition is stable. Recommendations.

article thumbnail

Press Release: Mydecine Secures Financing and Provides Company Update on Clinical Trials, Drug Development and Technology Initiatives

Cannabis Law Report

The Financing will allow the Company to continue progressing its R&D, clinical trials and technology initiatives. “I I’m proud of our accomplishments to date and look forward to kicking off multiple clinical trials in early 2022,” said CEO, Josh Bartch. DENVER, Dec. launched their app platform Mindleap 2.0

article thumbnail

Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”

TheAnswerPage

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).